| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Manufacturing and sale of industrial precision balls, rollers, cages and sheet metal parts used for bearing and other applications. Manufacturing and sale of ball screws, and large scale blowers.
Hadron is a premier A- VIII rated international hybrid fronting carrier, dedicated to transforming the insurance landscape for SMEs and lower middle-market insureds. As a modern market entrant, Hadron boasts a robust backing of $250 million in capital, and a strategic partnership network within the Altamont family. Hadron is an unencumbered, clean insurance entity specializing in custom insurance solutions for todays risk landscape. Our commitment to excellence is demonstrated in our top-tier operational frameworks and cutting-edge technology built to exceed expectations of partners and clients.
Fair. Rude. But fair. Lets take the second question first. In competitive cycling, Domestiques are riders who lead the pack, breaking headwinds to make the journey easier for the team. And its the love of doing the hard, foundational, gritty and unglamorous work that informs everything we do. Now, to your first question. Domestique is a management consultant company that helps businesses scale through go-to-market operations (aka Revenue Operations or RevOps). Not sure what that answer means? No sweat. We, in the next paragraph. will make it as long-winded as possible. We are Rhys Williams and Alex Biale, co-founders of Domestique. We have a combined 25+ years in go-to-market operations experience, translating CEO questions like "lets move up market" and "lets expand internationally" into best-in-class operations. Our expertise informed the development of a GTM operational framework that we use to help companies create, accelerate and optimize their revenue engines. And our understanding of building, scaling, funding and preparing your company for exit is what sets our expertise apart. Our mission? Empower your business to unlock growth levers to do great things. (What are growth levers? Theyre things like Capacity Planning, Lead Scoring, Customer Segmentation, Comp Strategy, and other terms that sound like things we just made up). Growing a business is hard and too often companies fail because they lack the preparation, agility and connective tissue to get through the hard part. We help by though strategic and technical services to align your business strategy with your go-to-market playbook. Because visualizing your goals, your outcomes and life-changing moments—thats where you come in. Getting you from mile marker to mile marker—thats where we come in. After all, thats our role as your Domestique—Your accelerator. Your guide. Your teammate.